ProCE Banner Events

Share

2024 Psychiatry Update

Register now for our Psychiatry Update 2024 series, which includes 7 dates in the spring and fall! This free program is offered in a virtual format with up to 6 CME/CE credits.

Join fellow healthcare professionals from around the country for this popular series, now in its ninth year! Join us online to hear from our world-class faculty as they discuss the latest diagnostic and therapeutic strategies in psychiatry today.

Pharmacists: 6.50 contact hours (0.65 CEUs)

Registered Nurses: 6.50 Nursing contact hours, including 6.50 hours of pharmacotherapy credit

Physician Assistants/Physician Associates: 6.50 AAPA Category 1 CME credits

Physicians: maximum of 6.50 AMA PRA Category 1 Credits

Psychologists: 6.50 APA CE Credits

Social Workers: 6.50 ASWB ACE CE Credits

Credits Available

6.5

Who Should Attend

This activity is intended for physicians, physician associates, nurse practitioners, registered nurses, pharmacists, social workers, and psychologists engaged in the care of patients with psychiatric illness.

Time and location

Saturday, November 16, 2024

9:00 AM - 4:15 PM Eastern Time (ET)

Virtual

Faculty
Robert O. Cotes, MD, DFAPA

Professor and Distinguished Physician
Director, Clinical & Research Program for Psychosis at Grady Health System
Department of Psychiatry and Behavioral Sciences
Emory University School of Medicine
Atlanta, Georgia

Joseph F. Goldberg, MD

Clinical Professor of Psychiatry
Icahn School of Medicine at Mount Sinai
New York, New York

Arash Javanbakht, MD

Director of the Stress, Trauma, and Anxiety Research Clinic
Wayne State University School of Medicine
Detroit, Michigan

Jonathan M. Meyer, MD, DLFAPA

Voluntary Clinical Professor of Psychiatry
University of California, San Diego
Senior Academic Adviser
California Department of State Hospitals
San Diego, California

Michael Weaver, MD, DFASAM

Professor and Medical Director
Center for Neurobehavioral Research on Addiction
McGovern Medical School
The University of Texas Health Science Center at Houston
Houston, Texas

Kate Zhong, MD, MSc, FRCP

Research Professor
Department of Brain Health
School of Integrated Health Sciences
University of Nevada, Las Vegas
Las Vegas, Nevada

Agenda

9:00 AM - 9:05 AM: Opening Remarks by moderator Joseph F. Goldberg, MD 

9:05 – 10:05 AM: Silent Struggles: Bridging Gaps in PTSD Care for a Holistic Healing Journey—presented by Arash Javanbakht, MD

  • Explore the frontiers of PTSD care in this session, which will shine a spotlight on the existing gaps in current PTSD treatment modalities, providing a critical examination of where the gaps lie and their impact on individuals. Delve into the promising realm of emerging management strategies as we discuss innovative approaches that hold the potential to reshape and enhance PTSD care.

5-minute break

10:10 AM - 11:10 AM: Beyond the First Line: Navigating the Crossroads of MDD Treatment Switching and Augmentation Strategies—presented by Joseph F. Goldberg, MD 

  • When a patient with MDD does not respond to a first-line agent, it can be difficult to decide whether to switch or augment therapy. This session will cover the evidence for switching and augmenting treatment and include an overview of the evidence for augmentation agents in the treatment of MDD, reinforced through patient cases.

11:15 AM - 12:15 PM: Restoring Serenity: Evidence-Based Strategies for Managing Agitation in Alzheimer’s Disease—presented by Kate Zhong, MD, MSc, FRCP   

  • This session will delve into the complex realm of agitation associated with dementia due to Alzheimer’s disease, exploring its causes, impact, and effective management strategies. From unraveling the underlying triggers to discussing compassionate approaches, this session aims to equip healthcare professionals with the knowledge and tools needed to effectively manage the challenges of agitation in Alzheimer’s-related dementia.

5-minute break

12:20 PM - 1:20 PM : Unlocking Potential: GLP-1 Agonists in Psychiatry - Promise, Pitfalls, and Perspectives—presented by Robert O. Cotes, MD 

  • This session delves into the burgeoning field of utilizing GLP-1 agonists in psychiatric care. It addresses the intersection of metabolic disorders such as diabetes and  obesity with serious mental illnesses and explores the potential of GLP-1 receptor agonists in managing mental health conditions. Attendees will gain insights into the therapeutic benefits and potential risks of using these agents in a psychiatric patient population

5-minute break

1:25 PM - 2:25 PM: A Holistic Approach to Managing ​Opioid Use Disorder—presented by Michael Weaver, MD, DFASAM 

  • Through expert-led discussions on identification and treatment of opioid use disorder, attendees will gain appreciation for and understanding of the biopsychosocial model of opioid use disorder, helping to reinforce clinical strategies that will promote safe, effective, patient-centered care.

5-minute break

2:30 PM – 4:00 PM: Pioneering Pathways: New and Emerging Agents for Schizophrenia—presented by Jonathan Meyer, MD, DLFAPA

  • In this session, participants will review the mechanism of disease of schizophrenia and hear about the potential impact of novel agents in changing the landscape of schizophrenia treatment in addressing symptom domains and adverse event profiles.

4:00 PM – 4:15 PM: Closing remarks by moderator Joseph F. Goldberg, MD

CME/CE Info

Target Audience
This activity is intended for physicians, physician associates, nurse practitioners, registered nurses, pharmacists, social workers, and psychologists engaged in the care of patients with psychiatric illness.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 6.5 contact hours, including 6.5 hours of pharmacotherapy credit. 

Continuing Pharmacy Education

CCO designates this continuing education activity for 6.5 contact hours (0.65 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - UAN will be specific to topics.

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6.5 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

Psychologist Continuing Education

Continuing education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.

This activity offers 6.5 continuing education credits for psychologists.

Social Work Continuing Education

As a Jointly Accredited Organization, Clinical Care Options, LLC is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 6.5 clinical continuing education credits.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

ABMS Approval Statement

Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory. Silent Struggles: Bridging Gaps in PTSD Care For a Holistic Healing Journey, Beyond the First Line: Navigating the Crossroads of MDD Treatment – Switching and Augmentation Strategies, Unlocking Potential: GLP-1 Agonists in Psychiatry – Promise, Pitfalls, and Perspectives, Overdose Prevention and Harm Reduction Strategies for Advanced Practice Providers, and Pioneering Pathways: New and Emerging Agents for Schizophrenia has met the requirements as a Lifelong Learning CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:  

ABMS Lifelong Learning CME Activity
Psychiatry and Neurology

Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, Agitation Associated with Dementia due to Alzheimer’s Disease has met the requirements as a Lifelong Learning CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:  

ABMS Lifelong Learning CME Activity
Family Medicine
Psychiatry and Neurology

Acknowledgement

Provided by Clinical Care Options, LLC

Supported by educational grants from AbbVie Inc. and Intra-Cellular Therapies, Inc.; Bristol Myers Squibb; and Otsuka America Pharmaceutical, Inc. and Lundbeck. 

Contact Information

For customer support please click here.

Mailing Address:


Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.